PD-L1 is overexpressed by several tumor types and confers resistance to pro-apoptotic signals (53, 54); while PD-1 is expressed on T cells upon antigen recognition and interferes with T cell activation when engaged with PD-L1. The gene discussed is CD274; the disease is neoplasm.